These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8784861)

  • 1. Neurochemical predictors and correlates of vulnerability to cocaine use.
    King RJ; Flowers C
    NIDA Res Monogr; 1996; 159():228-63; discussion 264-8. PubMed ID: 8784861
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemical mechanisms underlying responses to psychostimulants.
    Volkow ND; Fowler JS; Hitzemann R; Wang GJ
    NIDA Res Monogr; 1996; 159():322-48. PubMed ID: 8784863
    [No Abstract]   [Full Text] [Related]  

  • 3. Are monoamine metabolites in cerebrospinal fluid worth measuring?
    Potter WZ; Manji HK
    Arch Gen Psychiatry; 1993 Aug; 50(8):653-6. PubMed ID: 7688211
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism.
    Lanteri C; Salomon L; Torrens Y; Glowinski J; Tassin JP
    Neuropsychopharmacology; 2008 Jun; 33(7):1724-34. PubMed ID: 17805311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditioned dopaminergic activity.
    Schiff SR
    Biol Psychiatry; 1982 Feb; 17(2):135-54. PubMed ID: 7200377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. There is more to dopamine than just pleasure. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'.
    Lingford-Hughes A
    Behav Pharmacol; 2002 Sep; 13(5-6):367-70. PubMed ID: 12394412
    [No Abstract]   [Full Text] [Related]  

  • 7. Higher levels of CSF homovanillic acid in recently abstinent cocaine-dependent patients.
    Roy A; Berman J; Williams R; Kuhn C; Gonzalez B
    Am J Psychiatry; 2002 Jun; 159(6):1053-5. PubMed ID: 12042199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nimodipine inhibits cocaine-induced dopamine release and motor stimulation.
    Pani L; Carboni S; Kusmin A; Gessa GL; Rossetti ZL
    Eur J Pharmacol; 1990 Feb; 176(2):245-6. PubMed ID: 2311670
    [No Abstract]   [Full Text] [Related]  

  • 9. Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment.
    Robertson MW; Leslie CA; Bennett JP
    Brain Res; 1991 Jan; 538(2):337-9. PubMed ID: 2012975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some neurochemical correlates of "rebound" phenomenon observed during withdrawal after long-term exposure to 1, 4-benzodiazepines.
    Rastogi RB; Lapierre YD; Singhal RL
    Prog Neuropsychopharmacol; 1978; 2(1):43-54. PubMed ID: 31644
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic changes in human brain following acute exposure to gamma-hydroxybutyrate.
    Kish SJ; Kalasinsky KS; Schmunk G; Furukawa Y; Guttman M; Ang L
    Neurology; 2001 Jun; 56(11):1602-3. PubMed ID: 11402130
    [No Abstract]   [Full Text] [Related]  

  • 12. The physiology of cocaine craving and 'crashing'.
    Dackis CA; Gold MS; Sweeney DR
    Arch Gen Psychiatry; 1987 Mar; 44(3):298-300. PubMed ID: 3827524
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological approaches to cocaine addiction.
    Dackis CA; Gold MS
    J Subst Abuse Treat; 1985; 2(3):139-45. PubMed ID: 3912517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid monoamine precursors and metabolites in human neonates following in utero cocaine exposure: a preliminary study.
    Needlman R; Zuckerman B; Anderson GM; Mirochnick M; Cohen DJ
    Pediatrics; 1993 Jul; 92(1):55-60. PubMed ID: 8516085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid monoamine metabolites in cocaine patients: no relationship to cue-induced craving.
    Roy A; Berman J; Gonzalez B; Roy M
    J Psychopharmacol; 2002 Sep; 16(3):227-9. PubMed ID: 12236629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central stimulant abuse: neurochemistry and pharmacotherapy.
    Dackis CA; Gold MS; Pottash AL
    Adv Alcohol Subst Abuse; 1986; 6(2):7-21. PubMed ID: 2886014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine reward and cocaine craving: the role of dopamine in perspective.
    Wise RA
    NIDA Res Monogr; 1994; 145():191-206. PubMed ID: 8742814
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.
    Satel SL; Price LH; Palumbo JM; McDougle CJ; Krystal JH; Gawin F; Charney DS; Heninger GR; Kleber HD
    Am J Psychiatry; 1991 Dec; 148(12):1712-6. PubMed ID: 1957935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.
    Antkiewicz-Michaluk L; Filip M; Michaluk J; Romańska I; Przegaliński E; Vetulani J
    J Neural Transm (Vienna); 2007 Mar; 114(3):307-17. PubMed ID: 16897599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum.
    Sorg BA; Kalivas PW
    Brain Res; 1991 Sep; 559(1):29-36. PubMed ID: 1782559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.